The Patent Finder

Terms ending in 2043

Sandoz AG

Every in-force patent on Sandoz AG's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,590,095Crystalline Forms of an Orally Available, Selective Kit and Pdgfr Kinase Inhibitor
In force
 · High confidence
Sandoz AGIn forceHigh confidence
US 12,533,468Automatic Drug Delivery Device
In force
 · High confidence
Novartis AGIn forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Sandoz AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited